Insider · CIK 0001964335
Adam Morgan
Files at HRTX (HERON THERAPEUTICS, INC. /DE/). First filing Aug 12, 2025, latest Aug 12, 2025.
Adam Morgan files SEC Form 4 as director at HRTX (HERON THERAPEUTICS, INC. /DE/). Since Aug 12, 2025, Adam Morgan has reported 1 open-market buy worth $2.6M and 0 open-market sells worth $0, the latest filed on Aug 12, 2025.
A track record needs three past buys with six months of prices behind them; Adam Morgan has 0, so none is measured yet.
The newest scored trade: bought $2.6M of HRTX on Aug 8, 2025, filed Aug 12, 2025, scored 54 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
HRTX: HERON THERAPEUTICS, INC. /DE/
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 54Moderate | HERON THERAPEUTICS, INC. /DE/ | $2.6M 1,766,546 shares | +25% | - |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 30, 2026 | HRTX HERON THERAPEUTICS, INC. /DE/ | AGrant or award Common Stock | +53,960 | $0.00 | $0 | 123,737 | Feb 3, 2026 |
| Aug 8, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | POpen-market purchase Common Stockindirect: By Velan Capital Master Fund LP | +1,766,546 | $1.50 | $2.6M | 8,753,290 | Aug 12, 2025 |
| Aug 8, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | POpen-market purchase Series A Convertible Preferred Stockderivativeindirect: By Velan Capital Master Fund LP | +70,012 | $15.00 | $1.1M | 70,012 | Aug 12, 2025 |
| Jan 30, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | AGrant or award Common Stock | +17,950 | $0.00 | $0 | 69,777 | Feb 3, 2025 |
| Jan 30, 2025 | HRTX HERON THERAPEUTICS, INC. /DE/ | AGrant or award Stock Option (Right to Buy)derivative | +35,900 | $1.73 | $62k | 35,900 | Feb 3, 2025 |
Questions about Adam Morgan
Answered from the filings on this page, as of the latest one.
Is Adam Morgan buying or selling?
Not in the last 12 months. Adam Morgan's latest open-market trade on SEC Form 4 was bought $2.6M of HRTX on Aug 8, 2025.
How did Adam Morgan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Adam Morgan has 0.
Where does Adam Morgan file Form 4?
Adam Morgan has filed Form 4 at HRTX (HERON THERAPEUTICS, INC. /DE/). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.